⌘K

Login Start Free

Home/Filings/4/0001213900-18-016321

4//SEC Filing

Ludwig Dale L. 4

Accession 0001213900-18-016321

CIK 0001388320other

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 5:08 PM ET

Size

4.5 KB

Accession

0001213900-18-016321

Insider Transaction Report

Form 4

Period: 2018-11-19

Actinium Pharmaceuticals, Inc.ATNM

Chief Scientific Officer

Transactions

Purchase
Common Stock
2018-11-19$0.45/sh+10,000$4,499→ 10,000 total

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Actinium Pharmaceuticals, Inc.

CIK 0001388320

Entity typeother

Related Parties

1

filerCIK 0001727406

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 5:08 PM ET
Size: 4.5 KB

View on SEC.gov